GOODYEAR, Arizona – Reds All-Star shortstop Elly De La Cruz brought another four months of fluency to his English-only media skills since last season and a billion-dollar bounce to his step as ...

Elly De La Cruz is picking up right where he left off. The Cincinnati Reds phenom got his spring training off to the best start possible Saturday, as he crushed a high-flying solo home run in the ...

Heading into the 2025 season, Cincinnati Reds star Elly De La Cruz has made a subtle but important change as he looks to cut down on his strikeout rate and improve contact. Per Charlie Goldsmith ...

De La Cruz went 2-for-2 with two solo home runs in Saturday's split-squad game against the Guardians. Not only did he homer twice, De La Cruz homered from both sides of the plate in his first ...

De La Cruz has tweaked his batting stance in hopes that it will help him cut down on strikeouts, Charlie Goldsmith of Charlie's Chalkboard reports. De La Cruz has opened up his stance a bit and is ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

16:22 EST Eli Lilly (LLY) files automatic mixed securities shelf See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investmen ...

Eli Lilly (LLY) announced the launch of 7.5 mg and 10 mg Zepbound single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program. Lilly also reduced the price of the 2.5 mg ...

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...